Breast cancer-related lymphedema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female, aged 30 to 75; 2. Upper limb lymphedema diagnosed after unilateral breast cancer surgery (ISL stage I-II); 3. At least 3 months after the completion of surgery, radiotherapy and chemotherapy, the condition is stable and there is no evidence of disease recurrence. 4. Be capable of understanding and implementing breathing training instructions; 5. The patient or their family members sign the informed consent form and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1.ISL Stage III severe lymphedema or acute infections such as erysipelas; 2.Bilateral lymphedema or limb swelling due to other causes (cardiac, renal, etc.); 3.The affected limb has an active tumor or metastasis. 4.Individuals with known neurological disorders affecting autonomic nervous system function (such as Parkinson's disease); 5.Severe cognitive impairment or mental illness; 6.Severe cardiopulmonary disease (NYHA Class III-IV, resting dyspnea), respiratory dysfunction, or active pulmonary infection; 7.Deep vein thrombosis of the upper extremities or uncontrolled hypertension (>=160/100 mmHg), implantation of a cardiac pacemaker or defibrillator; 8.Currently taking medications that affect autonomic nervous system function (such as beta-blockers); 9.Received treatment for systemic lymphedema within the past 3 months or participated in other clinical trials;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PHQ-9;Upper Arm Circumference/Volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| FACT-B(V4.0);Handgrip strength test;6-minute walk test;heart rate variability;International Physical Activity Questionnaire;Ultrasound imaging;GAD-7;LYMPH-Q; | — |
Countries
China
Contacts
Shanghai Jing'an District Central Hospital